Biotech’s Next Goal: ‘Addressing Resistance’ In The ADC Space
Indispensable Value Of Partnerships Discussed by German Biopharma
George Badescu, chief business officer at Heidelberg Pharma, discusses antibody-drug conjugate development, partnership styles and the appetite for risk-taking in the biopharma industry.
